Author: Bill Snyder
Second forum on diversity and inclusion to be held June 23
Jun. 17, 2020—The next virtual forum on diversity and inclusion for the Vanderbilt University Medical Center community will be held from 9-10 a.m. Tuesday, June 23.
Online forum on diversity and inclusion attracts more than 750 from VUMC community
Jun. 11, 2020—Led by André Churchwell, MD, Vice Chancellor of Equity, Diversity and Inclusion at Vanderbilt University and Chief Diversity Officer at VUMC, the hour-long conversation, spurred by the nation grappling with the death of George Floyd and other black Americans, was meant to encourage members of the VUMC community to discuss racism and unconscious bias, and offer an opportunity to support and engage with each other during this particularly difficult time.
VUMC Office of Health Equity holds webinar on racism, health and health care
Jun. 10, 2020—The nation is now focused on the deaths of black citizens in police custody but systemic racism permeates every facet of American society including health care, according to panelists who participated in a webinar presented last week by the Vanderbilt University Medical Center Office of Health Equity.
Vanderbilt, AstraZeneca collaborate on new COVID-19 antibody research
Jun. 9, 2020—After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio.
Potential new cancer target
Jun. 4, 2020—Vanderbilt researchers have discovered the involvement of a certain type of adenosine receptor in mediating signaling that supports tumor growth and metastasis.
Remdesivir helps reduce COVID-19 recovery time: study
Jun. 4, 2020—The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine.
Research probes why COVID-19 seems to spare young children
May. 27, 2020—Lung disease experts at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children.
VUMC research ramps up in COVID-19 transition
May. 21, 2020—As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center.
Academy of Nutrition and Dietetics honors Silver
May. 21, 2020—Heidi Silver, RDN, MS, PhD, an internationally known registered dietitian and nutrition scientist at VUMC, is the recipient of the 2020 Excellence in Research Practice Award from the Academy of Nutrition and Dietetics.
VUMC Research Enterprise begins ramping up
May. 19, 2020—As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center.
Antibodies eye Pacific Island “fever”
May. 14, 2020—Vanderbilt Vaccine Center team isolates monoclonal antibodies against Ross River virus, which causes rash, fever and debilitating muscle and joint pain lasting three to six months.
Pioneering nephrologist William Stone mourned
May. 12, 2020—William J. Stone, MD, nephrologist and professor of Medicine, emeritus, who retired in December after 50 years as a member of the faculty of the Vanderbilt University School of Medicine, died Monday, May 11, at his home in Nashville. He was 83.
